Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the searchwpcro domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/skillsnuthstg/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/skillsnuthstg/wp-includes/functions.php on line 6131
Past Courses from 18 March, 2024. – 10 October, 2023. – Newcastle Hospitals Clinical Skills Academy
Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "tribe-events-filterbar-views-filter-bar-slider-js" was enqueued with dependencies that are not registered: tribe-swiper. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /nas/content/live/skillsnuthstg/wp-includes/functions.php on line 6131
Skip navigation

Home > tumours

Courses

Name: Targeted Treatments and Immunotherapy for Solid Tumours: Demystifying the Science – September 2024
Start: 2024-09-05T09:30:00+01:00
End: 2024-09-05T12:30:00+01:00
Location: Virtual delivery via MS Teams

List
Month

September 2024

Gene therapy for cancer concept illustration – slim for course

5 September, 2024. 9:30 am - 12:30 pm

Targeted Treatments and Immunotherapy for Solid Tumours: Demystifying the Science

Targeted Treatments and Immunotherapy for Solid Tumours: Demystifying the Science – September 2024

Virtual delivery via MS Teams

This course gives cancer nurses and trial staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies with patients and colleagues.